Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Teva
Accenture
Fish and Richardson
Covington
US Department of Justice
Citi
Healthtrust
Moodys

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,452,808

« Back to Dashboard

Summary for Patent: 4,452,808

Title: 4-Aminoalkyl-2(3H)-indolones
Abstract:A series of new chemical compounds which are 4-aminoalkyl-2(3H)-indolones has been demonstrated to be D.sub.2 -agonists useful for treating hypertension. A representative compound of the series is 4-di-n-propylaminoethyl-2(3H)-indolone.
Inventor(s): Gallagher, Jr.; Gregory (Collegeville, PA)
Assignee: Smithkline Beckman Corporation (Philadelphia, PA)
Application Number:06/447,564
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

International Patent Family for Patent: 4,452,808

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland77849► Subscribe
Finland834421► Subscribe
Spain543593► Subscribe
Spain8604143► Subscribe
Spain527827► Subscribe
Spain8600239► Subscribe
Denmark562183► Subscribe
Denmark156514► Subscribe
Algeria587► Subscribe
Egypt16556► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Julphar
Express Scripts
Federal Trade Commission
Chinese Patent Office
US Department of Justice
Chubb
Fish and Richardson
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot